New inhaler aims to clear stubborn lung mucus
NCT ID NCT06603246
Summary
This study is testing a new inhaled drug called GDC-6988 to see if it is safe and can help people with chronic lung diseases where thick mucus builds up. It will involve about 128 adults with conditions like COPD or bronchiectasis. Researchers will measure how the drug affects mucus thickness and the lungs' ability to clear it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Accel Research Site - Achieve - Birmingham - ERN - PPDS
WITHDRAWNVestavia Hills, Alabama, 35216-1927, United States
-
Stanford Center for Excellence in Pulmonary Biology
RECRUITINGPalo Alto, California, 94304, United States
-
TTS Research
COMPLETEDBoerne, Texas, 78006, United States
-
UPMC Montefiore Hospital
RECRUITINGPittsburgh, Pennsylvania, 15213 3236, United States
-
University of Alabama at Birmingham
RECRUITINGBirmingham, Alabama, 35233, United States
-
University of Kansas Medical Center-Kansas City-3901 Rainbow Blvd
RECRUITINGKansas City, Kansas, 66160 8500, United States
-
University of North Carolina Clinical Research Center
RECRUITINGChapel Hill, North Carolina, 27514, United States
Conditions
Explore the condition pages connected to this study.